Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary XbioTM technology to reduce the impact of biofilm based infections in human health.

Reporting Calendar

Reporting date Details of report
31 October 2023 Quarterly Report
31 August 2023 Half-Yearly Report
31 July 2023 Quarterly Report
26 May 2023 FY22 AGM Chair & Managing Director Address
30 April 2023 Annual Report / Quarterly Report
28 February 2023 Preliminary Final Report
2 February 2023 General Meeting
30 January 2023 Quarterly Report

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 8607 5124
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474